Vascular patterns in basal cell carcinoma: Dermoscopic, confocal and histopathological perspectives.
basal cell
biomarkers
carcinoma
confocal reflectance
dermoscopy
histology
microscopy
microvessels
Journal
Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
20
08
2018
accepted:
13
12
2018
entrez:
5
4
2019
pubmed:
5
4
2019
medline:
5
4
2019
Statut:
ppublish
Résumé
Basal cell carcinoma (BCC) is the most prevalent skin cancer in the Caucasian population. A variety of different phenotypic presentations of BCC are possible. Although BCCs rarely metastasize, these tumors commonly destroy underlying tissues and should therefore be treated promptly. As vascular formation and angiogenesis are indicators of tumor development and progression, the presence of blood vessels, their morphology and architecture are important markers in skin lesions, providing critical information towards pathogenesis and diagnosis. BCC commonly lacks pigmentation, therefore it is important to emphasize the usefulness of vascular feature detection, recognition, quantification and interpretation. To answer the question of whether vascular patterns observed on dermoscopy, reflectance confocal microscopy (RCM) and histopathology might reflect the biologic behavior of BCCs, we undertook this review article. Several studies have sought, by various means, to identify vascular features associated with the more aggressive BCC phenotypes. Dermoscopic vascular pattern assessment can facilitate diagnostic discrimination between BCC subtypes, more aggressive BCCs displaying less or no pink coloration and a relative absence of central tumor vessels. RCM, a novel, non-invasive imaging technique, allows for the quantification of blood vessel size, density, and flow intensity in BCCs. BCCs are distinguished on RCM chiefly by vessels that branch and intertwine between neoplastic aggregates, a pattern strongly reflecting tumor neo-angiogenesis. The analysis of these vascular morphological and distribution patterns can provide further support in the diagnosis, assessment, or monitoring of BCCs. Histopathology shows significantly higher microvessel densities in the peritumoral stroma of BCCs, when compared to normal skin or benign tumors. This angiogenic response in the stroma is associated with local aggressiveness, therefore the quantification of peritumoralmicrovessels may further assist with tumor evaluation. How dermoscopy and RCM vascular patterns in BCC correlate with histopathological subtype and thus help in discriminating aggressive subtypes definitely deserves further investigation.
Identifiants
pubmed: 30944604
doi: 10.3892/ol.2019.10070
pii: OL-0-0-10070
pmc: PMC6444327
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
4112-4125Références
Science. 1999 Jun 18;284(5422):1994-8
pubmed: 10373119
Arch Dermatol. 2000 Aug;136(8):1012-6
pubmed: 10926737
Nature. 2000 Sep 14;407(6801):249-57
pubmed: 11001068
Cancer Metastasis Rev. 2000;19(1-2):109-20
pubmed: 11191049
Lancet. 2001 Feb 17;357(9255):539-45
pubmed: 11229684
Clin Dermatol. 2002 May-Jun;20(3):248-54
pubmed: 12074860
Clin Dermatol. 2002 May-Jun;20(3):268-9
pubmed: 12074864
Skin Res Technol. 2002 Aug;8(3):141-7
pubmed: 12236882
Br J Dermatol. 2002 Nov;147(5):841-52
pubmed: 12410692
Arch Dermatol. 2002 Nov;138(11):1494-7
pubmed: 12437456
J Am Acad Dermatol. 2002 Dec;47(6):869-74
pubmed: 12451371
J Cutan Pathol. 2002 Nov;29(10):585-9
pubmed: 12453295
J Dermatol. 2003 Jan;30(1):33-41
pubmed: 12598707
Int Arch Allergy Immunol. 2003 Mar;130(3):216-23
pubmed: 12660426
J Dermatol. 2003 Apr;30(4):306-13
pubmed: 12707467
Lancet. 1992 Nov 7;340(8828):1120-4
pubmed: 1279332
J Pathol. 2003 Jul;200(3):308-13
pubmed: 12845626
Br J Dermatol. 2003 Jul;149(1):105-10
pubmed: 12890202
J Biol Chem. 1992 Jun 5;267(16):10931-4
pubmed: 1375931
Hum Pathol. 1992 Jul;23(7):755-61
pubmed: 1377162
Lab Invest. 1992 Sep;67(3):331-7
pubmed: 1383607
Histol Histopathol. 2004 Jan;19(1):37-42
pubmed: 14702169
Pathol Res Pract. 2003;199(11):705-12
pubmed: 14708636
Head Neck. 2004 May;26(5):396-400
pubmed: 15122655
Cancer Res. 2004 May 1;64(9):2941-55
pubmed: 15126324
Br J Dermatol. 2004 Jun;150(6):1112-6
pubmed: 15214896
Microvasc Res. 2004 Nov;68(3):258-64
pubmed: 15501245
Arch Dermatol. 2004 Dec;140(12):1485-9
pubmed: 15611426
JAMA. 2005 Aug 10;294(6):681-90
pubmed: 16091570
Dermatol Surg. 2005 Dec;31(12):1710-3
pubmed: 16336893
Nature. 2005 Dec 15;438(7070):932-6
pubmed: 16355210
Arch Pathol Lab Med. 2006 Jan;130(1):45-51
pubmed: 16390237
Mod Pathol. 2006 Feb;19 Suppl 2:S127-47
pubmed: 16446711
J Invest Dermatol. 2006 May;126(5):1143-51
pubmed: 16528365
Cancer. 2006 Jul 1;107(1):193-200
pubmed: 16615102
Dermatol Surg. 2006 Mar;32(3):423-5
pubmed: 16640692
Br J Cancer. 2006 Jun 19;94(12):1823-32
pubmed: 16773076
J Natl Cancer Inst. 1990 Jan 3;82(1):4-6
pubmed: 1688381
J Eur Acad Dermatol Venereol. 2006 Sep;20(8):916-20
pubmed: 16922937
N Engl J Med. 1991 Jan 3;324(1):1-8
pubmed: 1701519
Arch Dermatol. 2006 Oct;142(10):1318-22
pubmed: 17043187
Dermatol Surg. 2006 Nov;32(11):1398-406
pubmed: 17083595
J Am Acad Dermatol. 2007 Mar;56(3):380-6
pubmed: 17097387
Cancer Cell. 2007 Jun;11(6):526-38
pubmed: 17560334
J Am Acad Dermatol. 2007 Oct;57(4):644-58
pubmed: 17630045
Dermatol Surg. 2008 May;34(5):610-9
pubmed: 18261097
J Am Acad Dermatol. 2008 Aug;59(2):268-74
pubmed: 18550207
Int J Dermatol. 2008 Oct;47(10):1015-8
pubmed: 18986346
J Am Acad Dermatol. 2009 Aug;61(2):230-41
pubmed: 19398144
J Am Acad Dermatol. 2010 Jan;62(1):67-75
pubmed: 19828209
Semin Cell Dev Biol. 2010 Feb;21(1):33-9
pubmed: 19896548
Am Surg. 2009 Dec;75(12):1183-8
pubmed: 19999909
J Dtsch Dermatol Ges. 2010 Jun;8(6):400-10
pubmed: 20141551
Am J Public Health. 2010 Apr;100(4):735-41
pubmed: 20167900
Arch Dermatol. 2010 Mar;146(3):353-4
pubmed: 20231518
Bull Cancer. 2010;97:29-43
pubmed: 20418202
J Eur Acad Dermatol Venereol. 2011 Mar;25(3):358-61
pubmed: 20561131
J Am Acad Dermatol. 2010 Sep;63(3):377-86; quiz 387-8
pubmed: 20708470
J Skin Cancer. 2011;2011:241382
pubmed: 21152127
Semin Cutan Med Surg. 2010 Dec;29(4):218-31
pubmed: 21277535
J Med Life. 2011 Jan-Mar;4(1):63-74
pubmed: 21505576
Br J Dermatol. 2012 Feb;166(2):451-3
pubmed: 21824125
Eur J Dermatol. 2011 Jul-Aug;21(4):608-9
pubmed: 21865111
Dermatol Surg. 2012 Mar;38(3):392-9
pubmed: 22093161
Dev Cell. 2012 Feb 14;22(2):430-45
pubmed: 22306086
Skin Res Technol. 2013 Feb;19(1):e545-8
pubmed: 22356590
G Ital Dermatol Venereol. 2012 Apr;147(2):135-40
pubmed: 22481576
Actas Dermosifiliogr. 2012 Nov;103(9):784-9
pubmed: 22591654
Dermatol Ther. 2012 Jul-Aug;25(4):297-303
pubmed: 22950556
J Biomed Opt. 2012 Aug;17(8):085003
pubmed: 23224186
Int J Dermatol. 2013 Jun;52(6):718-21
pubmed: 23679878
Dermatol Pract Concept. 2012 Jul 31;2(3):203a02
pubmed: 23785604
Skin Res Technol. 2011 Aug;17(3):278-87
pubmed: 23815446
Hippokratia. 2012 Jan;16(1):29-34
pubmed: 23930054
Curr Proteomics. 2013 Sep;10(3):202-217
pubmed: 24228023
Science. 1987 Jan 23;235(4787):442-7
pubmed: 2432664
Eur J Cancer Clin Oncol. 1986 Oct;22(10):1205-9
pubmed: 2434333
Br J Dermatol. 2014 Aug;171(2):252-8
pubmed: 24354615
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2447-52
pubmed: 24550267
Biochim Biophys Acta. 1989 Feb;948(3):305-26
pubmed: 2465781
Acta Derm Venereol. 2014 Nov;94(6):677-82
pubmed: 24682274
Nature. 1989 May 4;339(6219):58-61
pubmed: 2469964
Dermatol Surg. 2014 Jul;40(7):718-24
pubmed: 25111342
Dermatol Surg. 2014 Jul;40(7):725-32
pubmed: 25111343
Dermatol Pract Concept. 2014 Jul 31;4(3):11-24
pubmed: 25126452
J BUON. 2014 Jul-Sep;19(3):780-6
pubmed: 25261667
Skin Res Technol. 2015 Aug;21(3):333-9
pubmed: 25345376
Rom J Morphol Embryol. 2014;55(3 Suppl):1191-6
pubmed: 25607405
Rom J Morphol Embryol. 2014;55(4):1437-41
pubmed: 25611278
PLoS One. 2015 Jan 23;10(1):e0112447
pubmed: 25615930
Indian J Dermatol Venereol Leprol. 2015 Nov-Dec;81(6):608-10
pubmed: 26515841
Pathol Res Pract. 1989 Nov;185(5):740-5
pubmed: 2696951
Oncol Lett. 2016 May;11(5):3019-3024
pubmed: 27123056
Oncol Lett. 2016 May;11(5):3354-3360
pubmed: 27123116
Dis Markers. 2016;2016:9831237
pubmed: 27578920
Acta Derm Venereol. 2017 May 8;97(5):612-616
pubmed: 28093600
Dermatology. 2017;233(2-3):199-204
pubmed: 28482338
Oncol Rep. 2017 Sep;38(3):1327-1340
pubmed: 28713981
Acta Dermatovenerol Croat. 2017 Oct;25(3):223-227
pubmed: 29252175
Exp Ther Med. 2018 Feb;15(2):1241-1246
pubmed: 29434710
Mol Clin Oncol. 2018 May;8(5):640-646
pubmed: 29725529
J Dermatol Surg Oncol. 1986 Aug;12(8):812-7
pubmed: 3016054
Am J Pathol. 1988 Nov;133(2):419-23
pubmed: 3189515
Arch Dermatol. 1977 Sep;113(9):1261-9
pubmed: 332091
Microvasc Res. 1985 May;29(3):371-86
pubmed: 3999993
Hautarzt. 1972 Apr;23(4):169-71
pubmed: 4558719
N Engl J Med. 1971 Nov 18;285(21):1182-6
pubmed: 4938153
HNO. 1981 Apr;29(4):112-7
pubmed: 6164676
J Am Acad Dermatol. 1984 Jun;10(6):1043-60
pubmed: 6736323
Mod Pathol. 1994 Jan;7(1):82-90
pubmed: 7512718
Am J Pathol. 1995 Jul;147(1):9-19
pubmed: 7541613
J Invest Dermatol. 1995 Sep;105(3):411-7
pubmed: 7545202
Nat Med. 1995 Jan;1(1):27-31
pubmed: 7584949
Nat Med. 1995 Feb;1(2):149-53
pubmed: 7585012
Am J Pathol. 1993 Aug;143(2):401-9
pubmed: 7688183
Cancer Res. 1993 Sep 15;53(18):4161-3
pubmed: 7689928
J Clin Invest. 1993 Jan;91(1):160-70
pubmed: 8423215
Hautarzt. 1996 Apr;47(4):264-72
pubmed: 8655309
Hum Pathol. 1996 Jul;27(7):695-700
pubmed: 8698314
Br J Cancer. 1997;75(4):559-65
pubmed: 9052411
J Cutan Pathol. 1997 Jul;24(6):364-9
pubmed: 9243364
Melanoma Res. 1997 Aug;7(4):307-11
pubmed: 9293480